Reappraisal of hepatic arterial infusion in the treatment of nonresectable liver metastases from colorectal cancer

Journal of the National Cancer Institute

Volumn 88, Issue 5, 1996, Pages 252-258

  Buyse, Marc ^a  

^a INTERNATIONAL DRUG DEVELOPMENT INSTITUTE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

FLOXURIDINE; FLUOROURACIL;

ARTICLE; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; COLORECTAL CANCER; DRUG RESPONSE; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LIVER METASTASIS; META ANALYSIS;

ANTIMETABOLITES, ANTINEOPLASTIC; COLORECTAL NEOPLASMS; FLOXURIDINE; FLUOROURACIL; HEALTH CARE COSTS; HEPATIC ARTERY; HUMANS; INFUSIONS, INTRA-ARTERIAL; LIVER NEOPLASMS;

EID: 0344051547     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/88.5.252     Document Type: Article

References (28)

1. Weiss L, Grundmann E, Torhorsi J, Hartveit F, Moberg I, Eder M, et al. Hematogenous metastatic patterns in colonic carcinoma: an analysis of 1541 necropsies. J Pathol 1986; 150:195-203.
2. Breedis C, Young C. The blood supply of neoplasm in the liver. Am J Pathol 1954;30:969-74.
3. Chen HS, Gross JF. Intra-arterial infusion of anticancer drugs: theoretic aspects of drug delivery and review of responses. Cancer Treat Rep 1980;64:31-40.
4. Ensminger WD, Gyves JW. Regional chemotherapy of neoplastic diseases. Pharmacol Ther 1983;21:277-93.
5. Sigurdson ER, Ridge JA, Kemeny N, Daly JM. Tumor and liver drug uptake following hepatic artery and portal vein infusion. J Clin Oncol 1987;5:1836-40.
6. Buroker T, Samson M, Correa J, Fraile R, Vaitkevicius VK. Hepatic artery infusion of 5-FUDR after prior systemic 5-fluorouracil. Cancer Treat Rep 1976;60:1277-9.
7. Oberfield RA, McCaffrey JA, Polio J, Clouse ME, Hamilton T. Prolonged and continuous percutaneous intra-arterial hepatic infusion chemotherapy in advanced metastatic liver adenocarcinoma from colorectal primary. Cancer 1979;44:414-23.
8. Patt YZ, Mavligit GM, Chuang VP, Wallace S, Johnston S, Benjamin RS, et al. Percutaneous hepatic arterial infusion (HAI) of mitomycin C and floxuridine (FUDR): an effective treatment for metastatic colorectal carcinoma in the liver. Cancer 1980;46:261-5.
9. Niederhuber JE, Ensminger W, Gyves J, Thrall J, Walker S, Cozzi E. Regional chemotherapy of colorectal cancer metastatic to the liver. Cancer 1984;53:1336-43.
10. Balch CM, Urist MM, Soong SJ, McGregor M. A prospective phase II clinical trial of continuous FUDR regional chemotherapy for colorectal metastases to the liver using a totally implantable drug infusion pump. Ann Surg 1983;198:567-73.
11. Hohn DC, Stagg RJ, Friedman MA, Hannigan JF Jr, Raynor A, Ignoffo RJ, et al. A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver: the Northern California Oncology Group trial. J Clin Oncol 1989;7:1646-54.
12. Kemeny N, Daly J, Reichman B, Geller N, Botet J, Oderman P. Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma. A randomized trial. Ann Intern Med 1987;107:459-65.
13. Martin JK Jr. O'Connell MJ, Wieand HS, Fitzgibbons RJ Jr, Mailliard JA, Rubin J, et al. Intra-arterial floxuridine vs systemic fluorouracil for hepatic metastases from colorectal cancer. A randomized trial. Arch Surg 1990;125:1022-7.
14. Chang AE, Schneider PD, Sugarbaker PH, Simpson C, Culnane M, Steinberg SM, et al. A prospective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases. Ann Surg 1987;206:685-93.
15. Kemeny MM, Goldberg D, Beatty JD, Blayney D, Browning S, Doroshow J, et al. Results of a prospective randomized trial of continuous regional chemotherapy and hepatic resection as treatment of hepatic metastases from colorectal cancer. Cancer 1986;57:492-8.
16. Rougier P, Laplanche A, Huguier M, Hay JM, Ollivier JM, Escat J. et al. Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: long-term results of a prospective randomized trial [see comment citation in Medline]. J Clin Oncol 1992; 10:1112-8.
17. Allen-Mersh TG, Earlam S, Fordy C, Abrams K, Houghton J. Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastasis [see comment citation in Medline]. Lancet 1994;344:1255-60.
18. Kemeny N, Seiter K, Niedzwiecki D, Chapman D, Sigurdson E, Cohen A, et al. A randomized trial of intrahepatic infusion of fluorodeoxyuridine with dexamethasone versus fluorodeoxyuridine alone in the treatment of metastatic colorectal cancer [see comment citation in Medline]. Cancer 1992;69:327-34.
19. Kemeny N, Cohen A, Seiter K, Conti JA, Sigurdson ER, Tao Y, et al. Randomized trial of hepatic arterial floxuridine, mitomycin, and carmustine versus floxuridine alone in previously treated patients with liver metastases from colorectal cancer. J Clin Oncol 1993;11:330-5.
20. Grage TB, Vassilopoulos PP, Shingleton WW, Jubert AV, Elias EG, Aust JB, et al. Results of a prospective randomized study of hepatic artery infusion with 5-fluorouracil versus intravenous 5-fluorouracil in patients with hepatic metastases from colorectal cancer: a Central Oncology Group study. Surgery 1979;86:550-5.
21. Modulation of fluorouracil by leucovorin in patients with evidence in terms of response rate, advanced colorectal cancer: Advanced Colorectal Cancer Meta-Analysis Project [see comment citation in Medline]. J Clin Oncol 1992;10:896-903.
22. Meta-analysis of randomized trials testing the biochemical modulation of 5-fluorouracil by methotrexate in metastatic colorectal cancer. Advanced Colorectal Cancer Meta-Analysis Project. J Clin Oncol 1994;12: 960-9.
23. Mantel H, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959;22:719-48.
24. Peto R, Pike MC, Armitage P, Breslow NE, Cox DR. Howard SV, et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer 1977;35:1-39.
25. Slud EV, Byar DP, Green SB. A comparison of reflected versus test-based confidence intervals for the median survival time, based on censored data. Biometrics 1984;40:587-600.
26. Cox DR. The analysis of binary data. London, England: Methuen. 1970.
27. Cox DR. Regression models and life tables (with discussion). J R Stat Soc (Br) 1972;34:187-220.
28. Expectancy or primary chemotherapy in patients with advanced asymptomatic colorectal cancer: a randomized trial. Nordic Gastrointestinal Tumor Adjuvant Therapy Group. J Clin Oncol 1992;10:904-11.